{"retracted":false,"update":{"timestamp":1472688000000,"doi":"10.1016/j.kint.2016.06.006","type":"erratum"},"doi":"10.1016/j.kint.2015.11.026","journal":"Kidney International","publisher":"Elsevier BV","title":"Greenbaum LA, Fila M, Ardissino G, et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int. 2016;89:701–711"}
